Profile data is unavailable for this security.
About the company
Shanghai MicroPort Endovascular MedTech Group Co Ltd is a China-based company primarily engaged in the research, development, production, and sales of interventional medical devices for the aorta and peripheral blood vessels. The Company's products are mainly categorized into aortic stents, peripheral vascular devices and others. The aortic stent products include thoracic aortic stent graft systems, abdominal aortic stent graft systems, and other surgical accessories. The peripheral vascular and other products mainly include intraoperative stent systems, peripheral arteries, peripheral veins, interventional oncology devices, and peripheral vascular surgical accessories. The Company conducts its businesses in domestic and overseas markets.
- Revenue in CNY (TTM)1.25bn
- Net income in CNY377.82m
- Incorporated2012
- Employees832.00
- LocationShanghai MicroPort Endovascular MedTech Group Co LtdNo. 1, Lane 3399, Kangxin HighwayPudong New AreaSHANGHAI 201318ChinaCHN
- Phone+86 2 138139300
- Fax+86 2 133750026
- Websitehttps://www.endovastec.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Qingdao Haier Biomedical Co Ltd | 2.26bn | 255.88m | 10.33bn | 2.81k | 40.07 | 2.39 | -- | 4.56 | 0.8144 | 0.8144 | 7.21 | 13.64 | 0.4008 | 4.31 | 5.12 | 806,199.10 | 4.68 | 10.87 | 5.92 | 14.12 | 45.31 | 49.21 | 11.67 | 24.08 | 2.41 | -- | 0.0205 | 28.14 | 0.1288 | 17.67 | -9.71 | 15.03 | -5.53 | 21.16 |
| Xiangyu Medical Co Ltd | 773.93m | 73.51m | 10.92bn | 2.34k | 142.59 | 5.39 | -- | 14.12 | 0.4789 | 0.4789 | 5.07 | 12.67 | 0.2548 | 1.01 | 11.40 | 330,597.70 | 2.35 | 8.54 | 3.26 | 10.17 | 65.98 | 66.78 | 9.22 | 28.37 | 0.9871 | -- | 0.2387 | 32.49 | -0.1717 | 11.71 | -54.68 | -4.41 | 83.55 | -- |
| Shanghai Microport EP MedTech Co Ltd | 458.70m | 52.26m | 11.00bn | 500.00 | 210.45 | 6.14 | -- | 23.98 | 0.111 | 0.111 | 0.9747 | 3.81 | 0.2395 | 1.33 | 6.85 | 917,403.00 | 2.73 | 0.9084 | 2.91 | 0.9579 | 58.24 | 64.95 | 11.39 | 4.09 | 10.17 | -- | 0.0032 | 0.00 | 25.51 | 28.61 | 815.36 | -- | 35.67 | -- |
| Beijing Wandong Medical Technolgy Co Ltd | 1.62bn | 14.41m | 11.10bn | 1.19k | 947.78 | 2.37 | -- | 6.85 | 0.0167 | 0.0167 | 2.26 | 6.66 | 0.2937 | 2.73 | 2.99 | 1,360,016.00 | 0.2623 | 4.51 | 0.304 | 5.21 | 31.59 | 42.82 | 0.8933 | 14.91 | 4.80 | -- | 0.0039 | 43.25 | 23.26 | 9.18 | -16.54 | -1.40 | -1.39 | 21.06 |
| Sansure Biotech Inc | 1.67bn | 271.49m | 11.19bn | 2.35k | 43.62 | 1.57 | -- | 6.70 | 0.4427 | 0.4427 | 2.45 | 12.31 | 0.1852 | 1.04 | 2.46 | 711,687.90 | 2.50 | 21.18 | 2.81 | 24.37 | 73.70 | 68.60 | 13.49 | 40.51 | 4.49 | -- | 0.1716 | 25.74 | 44.78 | 31.89 | -24.23 | 47.50 | 65.28 | -- |
| TINAVI Medical Technologies Co Ltd | 274.20m | -159.01m | 11.43bn | 307.00 | -- | 9.15 | -- | 41.67 | -0.3493 | -0.3493 | 0.6035 | 2.74 | 0.1673 | 2.18 | 7.63 | 893,155.40 | -10.37 | -8.02 | -11.54 | -9.16 | 70.09 | 69.64 | -62.01 | -63.51 | 2.94 | -15.75 | 0.1408 | -- | -14.85 | -4.87 | 22.54 | -- | 12.71 | -- |
| Eyebright Medical Technlgy (Bjng) Co Ltd | 1.48bn | 360.97m | 11.51bn | 2.29k | 31.60 | 4.09 | -- | 7.78 | 1.88 | 1.88 | 7.71 | 14.53 | 0.4048 | 1.89 | 3.34 | 644,799.40 | 9.90 | 10.50 | 11.54 | 12.04 | 62.91 | 75.13 | 24.45 | 31.92 | 3.28 | 24.66 | 0.1753 | 20.11 | 48.24 | 48.51 | 27.77 | 42.25 | 18.40 | -- |
| Shandong Weigao Orthopaedic Devce Co Ltd | 1.48bn | 266.86m | 11.53bn | 2.07k | 43.19 | 2.83 | -- | 7.81 | 0.6672 | 0.6672 | 3.70 | 10.18 | 0.2919 | 0.7798 | 5.17 | 714,278.40 | 5.36 | 9.00 | 6.58 | 11.05 | 64.22 | 74.07 | 18.37 | 24.98 | 4.28 | -- | 0.0011 | 22.90 | 13.18 | -1.59 | 99.22 | -12.72 | -3.40 | -- |
| Vcanbio Cell & Gene Engineering Corp Ltd | 1.47bn | 74.75m | 11.70bn | 2.01k | 151.75 | 3.15 | -- | 7.95 | 0.1647 | 0.1647 | 3.29 | 7.93 | 0.2778 | 1.92 | 2.35 | 730,874.40 | 1.07 | 1.24 | 1.51 | 1.76 | 67.29 | 68.07 | 3.85 | 4.20 | 1.60 | 4.90 | 0.0219 | 0.00 | -0.2705 | 2.71 | -5.73 | 15.09 | -11.35 | -- |
| Shanghai MicroPort Edvcl MdTch Grp CoLtd | 1.25bn | 377.82m | 11.95bn | 832.00 | 31.12 | 3.02 | -- | 9.55 | 3.12 | 3.12 | 10.27 | 32.10 | 0.2694 | 1.56 | 3.66 | 1,515,185.00 | 7.94 | 15.38 | 9.10 | 16.87 | 68.10 | 75.38 | 29.45 | 41.85 | 4.36 | -- | 0.0043 | 46.52 | 1.61 | 29.30 | 1.96 | 28.78 | 58.53 | 35.76 |
| Beijing Hotgen Biotech Co Ltd | 434.45m | -259.33m | 12.68bn | 903.00 | -- | 4.32 | -- | 29.18 | -3.04 | -3.04 | 4.98 | 31.63 | 0.1313 | 1.96 | 4.23 | 481,114.30 | -7.97 | 21.79 | -8.47 | 24.93 | 56.38 | 55.43 | -60.71 | 29.14 | 4.77 | -- | 0.0168 | 44.35 | -6.74 | 19.41 | -760.40 | -- | -10.29 | -- |
Data as of Feb 13 2026. Currency figures normalised to Shanghai MicroPort Endovascular MedTech Group Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
13.73%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nuode Asset Management Co., Ltd.as of 24 Jun 2024 | 4.59m | 3.73% |
| Harvest Fund Management Co., Ltd.as of 24 Jun 2024 | 3.52m | 2.86% |
| Caitong Fund Management Co., Ltd.as of 24 Jun 2024 | 2.27m | 1.85% |
| Hwabao WP Fund Management Co., Ltd.as of 30 Sep 2024 | 2.00m | 1.62% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 887.57k | 0.72% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2025 | 760.57k | 0.62% |
| Goldman Sachs Asset Management LPas of 30 Nov 2025 | 756.85k | 0.61% |
| E Fund Management Co., Ltd.as of 24 Jun 2024 | 752.39k | 0.61% |
| CITIC Securities Co., Ltd. (Invt Port)as of 24 Jun 2024 | 725.84k | 0.59% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 651.61k | 0.53% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
